Predicted norovirus resurgence in 2021–2022 due to the relaxation of nonpharmaceutical interventions associated with COVID-19 restrictions in England: a mathematical modeling study
Abstract Background To reduce the coronavirus disease burden in England, along with many other countries, the government implemented a package of non-pharmaceutical interventions (NPIs) that have also impacted other transmissible infectious diseases such as norovirus. It is unclear what future norov...
Main Authors: | Kathleen M. O’Reilly, Frank Sandman, David Allen, Christopher I. Jarvis, Amy Gimma, Amy Douglas, Lesley Larkin, Kerry L. M. Wong, Marc Baguelin, Ralph S. Baric, Lisa C. Lindesmith, Richard A. Goldstein, Judith Breuer, W. John Edmunds |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-11-01
|
Series: | BMC Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12916-021-02153-8 |
Similar Items
-
GII.4 Human Norovirus: Surveying the Antigenic Landscape
by: Michael L. Mallory, et al.
Published: (2019-02-01) -
Human Norovirus Infection in Dogs, Thailand
by: Kamonpan Charoenkul, et al.
Published: (2020-02-01) -
Deaths from Norovirus among the Elderly, England and Wales
by: John P. Harris, et al.
Published: (2008-10-01) -
norovirus
Published: (2007-03-01) -
In Vitro Replication of Human Norovirus
by: Sutonuka Bhar, et al.
Published: (2019-06-01)